Foley partners Adria Warren and Roger Strode are speaking in the upcoming Clinical Pathways Congress + Cancer Care Business Exchange on September 6 and 7. Warren, a member of the CBEx Advisory Board, is moderating the session “Risk & Rewards of Oncology Joint Ventures & Strategic Partnerships,” and Strode’s presentation is titled “Equity Funding in Health Care: The Case for Venture Capital & Private Equity.”
Risk & Rewards of Oncology Joint Ventures & Strategic Partnerships
The world of health care is changing quickly, and community oncology providers are examining new ways and methods to provide health care to their populations, including teaming with new and complementary business partners. Joint ventures can be a means to support service line development and collaboration in the delivery of care, and in many ways are becoming a new normal. But, they bring with them regulatory, transactional, and shared management complexities. This panel will provide an overview of the current landscape of oncology joint ventures and strategic partnerships and highlight important considerations for structuring, navigating, and implementing a transaction.
Equity Funding in Health Care: The Case for Venture Capital & Private Equity
This session will present a compelling case for the significance of venture capital and private equity funding within the health care sector, focusing specifically on its relevance to oncology. Attendees will gain insights into the motivations behind investments, exploring who is investing in what and the underlying reasons driving these decisions. The panel will distinguish between investments in digital platform/service companies and direct investments in physician practices, providing nuanced perspectives on their respective impacts. Additionally, commentary will be provided regarding the current phenomenon of “Retailer Retrenchment” in primary care investment, offering valuable insights into evolving trends and their implications. The Clinical Pathways Congress + Cancer Care Business Exchange brings together industry leaders, health care professionals, researchers, payment reform experts, and innovators to discuss and showcase transformative oncology delivery, payment, and business models.
To learn more and register, click here.
